Treatment of Advanced Squamous Cell Lung Cancer
Lung cancer is the deadliest cancer in the worldwide. Non-small cell lung cancer (NSCLC) accounts for 85% of lung tumor diagnoses. Squamous cell lung cancer (SQCLC) is a common pathological type, almost 20%-30% of NSCLC. Surgery, chemotherapy, and molecular targeted therapies are the mainstay of tre...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2016-10-01
|
| Series: | Chinese Journal of Lung Cancer |
| Subjects: | |
| Online Access: | http://dx.doi.org/10.3779/j.issn.1009-3419.2016.10.10 |
| _version_ | 1819181069876854784 |
|---|---|
| author | Yixiang ZHU Puyuan XING Junling LI |
| author_facet | Yixiang ZHU Puyuan XING Junling LI |
| author_sort | Yixiang ZHU |
| collection | DOAJ |
| description | Lung cancer is the deadliest cancer in the worldwide. Non-small cell lung cancer (NSCLC) accounts for 85% of lung tumor diagnoses. Squamous cell lung cancer (SQCLC) is a common pathological type, almost 20%-30% of NSCLC. Surgery, chemotherapy, and molecular targeted therapies are the mainstay of treatment for patients with SQCLC. But most patients are diagnosed at advanced stage so that they miss the chance of operation. While noteworthy outcomes have improved with adenocarcinoma of lung with epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs), a therapeutic plateau for advanced squamous cell lung cancer patients are still not solved. EGFR-TKIs are unsuitable for or mostly ineffective in advanced SQCLC. Patients with advanced SQCLC ramain treated with platinum based chemotherapy. This reciew systematicly describe the treatment of squamous cell carcinoma of the lung. |
| first_indexed | 2024-12-22T22:24:23Z |
| format | Article |
| id | doaj.art-e9db3e756c044d869dc98f425ba6a87b |
| institution | Directory Open Access Journal |
| issn | 1009-3419 1999-6187 |
| language | zho |
| last_indexed | 2024-12-22T22:24:23Z |
| publishDate | 2016-10-01 |
| publisher | Chinese Anti-Cancer Association; Chinese Antituberculosis Association |
| record_format | Article |
| series | Chinese Journal of Lung Cancer |
| spelling | doaj.art-e9db3e756c044d869dc98f425ba6a87b2022-12-21T18:10:36ZzhoChinese Anti-Cancer Association; Chinese Antituberculosis AssociationChinese Journal of Lung Cancer1009-34191999-61872016-10-011910pagepage10.3779/j.issn.1009-3419.2016.10.10Treatment of Advanced Squamous Cell Lung CancerYixiang ZHU0Puyuan XING1Junling LI2National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, ChinaNational Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, ChinaNational Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, ChinaLung cancer is the deadliest cancer in the worldwide. Non-small cell lung cancer (NSCLC) accounts for 85% of lung tumor diagnoses. Squamous cell lung cancer (SQCLC) is a common pathological type, almost 20%-30% of NSCLC. Surgery, chemotherapy, and molecular targeted therapies are the mainstay of treatment for patients with SQCLC. But most patients are diagnosed at advanced stage so that they miss the chance of operation. While noteworthy outcomes have improved with adenocarcinoma of lung with epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs), a therapeutic plateau for advanced squamous cell lung cancer patients are still not solved. EGFR-TKIs are unsuitable for or mostly ineffective in advanced SQCLC. Patients with advanced SQCLC ramain treated with platinum based chemotherapy. This reciew systematicly describe the treatment of squamous cell carcinoma of the lung.http://dx.doi.org/10.3779/j.issn.1009-3419.2016.10.10Lung neoplasmsChemotherapyTargeted therapy |
| spellingShingle | Yixiang ZHU Puyuan XING Junling LI Treatment of Advanced Squamous Cell Lung Cancer Chinese Journal of Lung Cancer Lung neoplasms Chemotherapy Targeted therapy |
| title | Treatment of Advanced Squamous Cell Lung Cancer |
| title_full | Treatment of Advanced Squamous Cell Lung Cancer |
| title_fullStr | Treatment of Advanced Squamous Cell Lung Cancer |
| title_full_unstemmed | Treatment of Advanced Squamous Cell Lung Cancer |
| title_short | Treatment of Advanced Squamous Cell Lung Cancer |
| title_sort | treatment of advanced squamous cell lung cancer |
| topic | Lung neoplasms Chemotherapy Targeted therapy |
| url | http://dx.doi.org/10.3779/j.issn.1009-3419.2016.10.10 |
| work_keys_str_mv | AT yixiangzhu treatmentofadvancedsquamouscelllungcancer AT puyuanxing treatmentofadvancedsquamouscelllungcancer AT junlingli treatmentofadvancedsquamouscelllungcancer |